$294M
$169,000
0.0% of portfolio
14,996
Q4 2024
New
$3.21B
$112,000
0.0% of portfolio
28,542
Q4 2024
Reduced 52.43%
$2.72B
$240,000
0.0% of portfolio
5,728
Q4 2024
New
$994M
$415,000
0.0% of portfolio
19,336
Q4 2024
New
$208M
$304,000
0.0% of portfolio
25,790
Q4 2024
New
$24.4B
$264,000
0.0% of portfolio
216
Q4 2024
Reduced 80.52%
$7.11B
$258,000
0.0% of portfolio
1,907
Q4 2024
New
$334M
$209,000
0.0% of portfolio
8,592
Q4 2024
New
$1.85B
$243,000
0.0% of portfolio
3,199
Q4 2024
New
$144B
$266,000
0.0% of portfolio
22,735
Q4 2024
Added 16.64%
-
$0
0.0% of portfolio
-
Q4 2024
Added 73.1%
$10.5B
$299,000
0.0% of portfolio
7,194
Q4 2024
New
$49.9B
$219,000
0.0% of portfolio
4,583
Q4 2024
New
$852M
$186,000
0.0% of portfolio
14,600
Q4 2024
New
$4.19B
$214,000
0.0% of portfolio
2,703
Q4 2024
Reduced 3.46%
$3.19B
$233,000
0.0% of portfolio
7,706
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
$7.1B
$329,000
0.0% of portfolio
5,435
Q3 2024
Added 0.83%
$50.8B
$206,000
0.0% of portfolio
3,473
Q4 2024
Added 15.5%
$599M
$466,000
0.0% of portfolio
4,735
Q4 2024
New
$934M
$246,000
0.0% of portfolio
23,657
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 4.99%
$112M
$20,000
0.0% of portfolio
21,978
Q2 2024
Reduced 8.97%
-
$0
0.0% of portfolio
-
Q4 2024
Added 3.57%
$0
$144,000
0.0% of portfolio
11,349
Q4 2024
Added 2.34%
Neumora Therapeutics Inc.
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 50.77%
$207M
$46,000
0.0% of portfolio
12,369
Q4 2024
New
$43.5B
$240,000
0.0% of portfolio
6,450
Q4 2024
Reduced 77.19%
$5.92B
$456,000
0.0% of portfolio
2,887
Q4 2024
Added 63.48%
$8.6M
$28,000
0.0% of portfolio
37,342
Q2 2023
New
$226M
$76,000
0.0% of portfolio
32,322
Q4 2024
Reduced 22.98%
$7.2B
$200,000
0.0% of portfolio
4,904
Q4 2024
New
$16.1B
$110,000
0.0% of portfolio
19,027
Q4 2024
Reduced 0.32%
$462M
$197,000
0.0% of portfolio
17,001
Q4 2024
New
$1.4B
$421,000
0.0% of portfolio
31,966
Q4 2024
New
$3.3B
$208,000
0.0% of portfolio
3,898
Q4 2024
New
$22.6B
$452,000
0.0% of portfolio
5,017
Q4 2024
Reduced 76.4%
$28.5B
$230,000
0.0% of portfolio
1,974
Q4 2024
Reduced 85.33%
$439M
$98,000
0.0% of portfolio
36,993
Q4 2024
New
$0
$177,000
0.0% of portfolio
14,461
Q3 2024
Added 0.01%
$0
$193,000
0.0% of portfolio
17,178
Q4 2024
Added 2.01%
$0
$126,000
0.0% of portfolio
15,000
Q2 2024
Reduced 6.25%
Nuveen Churchill Direct Lend
-
$0
0.0% of portfolio
-
Q4 2024
New
$0
$92,000
0.0% of portfolio
10,378
Q4 2024
Reduced 0.97%
$0
$118,000
0.0% of portfolio
15,115
Q4 2024
Reduced 39.55%
$904M
$446,000
0.0% of portfolio
24,642
Q4 2024
New
$583M
$150,000
0.0% of portfolio
17,629
Q2 2024
Reduced 41.49%
$1.67B
$210,000
0.0% of portfolio
4,973
Q4 2024
New
$8.96B
$234,000
0.0% of portfolio
5,685
Q4 2024
New
$220M
$53,000
0.0% of portfolio
10,617
Q4 2024
New